Cargando…
p53 induces distinct epigenetic states at its direct target promoters
BACKGROUND: The tumor suppressor protein p53 is a transcription factor that is mutated in many cancers. Regulation of gene expression by binding of wild-type p53 to its target sites is accompanied by changes in epigenetic marks like histone acetylation. We studied DNA binding and epigenetic changes...
Autores principales: | Vrba, Lukas, Junk, Damian J, Novak, Petr, Futscher, Bernard W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585595/ https://www.ncbi.nlm.nih.gov/pubmed/18922183 http://dx.doi.org/10.1186/1471-2164-9-486 |
Ejemplares similares
-
Epigenetic silencing of lncRNA
MORT in 16 TCGA cancer types
por: Vrba, Lukas, et al.
Publicado: (2018) -
Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
por: Vrba, Lukas, et al.
Publicado: (2017) -
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers
por: Vrba, Lukas, et al.
Publicado: (2015) -
DNA methylation changes in biomarker loci occur early in cancer progression
por: Vrba, Lukas, et al.
Publicado: (2020) -
miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer
por: Vrba, Lukas, et al.
Publicado: (2013)